Search research articles
Contact Us
Filters
Showing results (1-10 of 65) with videos related to
Page
of 7
Sort By:
The New England Journal of Medicine
|
January 18, 2023
Dapagliflozin in Heart Failure with Preserved Ejection Fraction
Elric Zweck, Ralf Westenfeld
The Lancet. Diabetes & Endocrinology
|
January 27, 2019
GLP-1 receptor agonists and cardiovascular disease: drug-specific or class effects?
Elric Zweck, Michael Roden
JACC. Heart Failure
|
November 8, 2023
Methodologic Challenges of Propensity Score-Based Analyses
Elric Zweck, Tobias Kurth
Circulation
|
October 6, 2025
Response by Zweck and Møller to Letter Regarding Article, "Microaxial Flow Pump Use and Renal Outcomes in Infarct-Related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial"
Elric Zweck, Jacob Eifer Møller
Journal of the American College of Cardiology
|
October 25, 2023
Beta-Blockers in Stable Ischemic Heart Disease
Elric Zweck, Shady Abohashem, Dhaval Kolte
The New England Journal of Medicine
|
November 21, 2019
Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes
Elric Zweck, Ralf Westenfeld, Julia Szendroedi
Obesity Surgery
|
February 24, 2021
Predictors of Postprandial Hypoglycemia After Gastric Bypass Surgery: a Retrospective Case-Control Study
Elric Zweck, Matthias Hepprich, Marc Y Donath
Methodist Debakey Cardiovascular Journal
|
April 14, 2020
Cardiogenic Shock in the Setting of Acute Myocardial Infarction
Navin K Kapur, Katherine L Thayer, Elric Zweck
Deutsche Medizinische Wochenschrift (1946)
|
February 1, 2019
[The Diabetic Heart and Heart Failure - Update on Mechanisms and Therapy]
Elric Zweck, Julia Szendrödi, Malte Kelm, et al.
Journal of the Society for Cardiovascular Angiography & Interventions
|
April 15, 2025
Profiling of Cardiogenic Shock: Incorporating Machine Learning Into Bedside Management
Elric Zweck, Song Li, Daniel Burkhoff, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 65) with videos related to
Sort By:
Page
of 7
The New England Journal of Medicine
|
January 18, 2023
Dapagliflozin in Heart Failure with Preserved Ejection Fraction
Elric Zweck, Ralf Westenfeld
The Lancet. Diabetes & Endocrinology
|
January 27, 2019
GLP-1 receptor agonists and cardiovascular disease: drug-specific or class effects?
Elric Zweck, Michael Roden
JACC. Heart Failure
|
November 8, 2023
Methodologic Challenges of Propensity Score-Based Analyses
Elric Zweck, Tobias Kurth
Circulation
|
October 6, 2025
Response by Zweck and Møller to Letter Regarding Article, "Microaxial Flow Pump Use and Renal Outcomes in Infarct-Related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial"
Elric Zweck, Jacob Eifer Møller
Journal of the American College of Cardiology
|
October 25, 2023
Beta-Blockers in Stable Ischemic Heart Disease
Elric Zweck, Shady Abohashem, Dhaval Kolte
The New England Journal of Medicine
|
November 21, 2019
Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes
Elric Zweck, Ralf Westenfeld, Julia Szendroedi
Obesity Surgery
|
February 24, 2021
Predictors of Postprandial Hypoglycemia After Gastric Bypass Surgery: a Retrospective Case-Control Study
Elric Zweck, Matthias Hepprich, Marc Y Donath
Methodist Debakey Cardiovascular Journal
|
April 14, 2020
Cardiogenic Shock in the Setting of Acute Myocardial Infarction
Navin K Kapur, Katherine L Thayer, Elric Zweck
Deutsche Medizinische Wochenschrift (1946)
|
February 1, 2019
[The Diabetic Heart and Heart Failure - Update on Mechanisms and Therapy]
Elric Zweck, Julia Szendrödi, Malte Kelm, et al.
Journal of the Society for Cardiovascular Angiography & Interventions
|
April 15, 2025
Profiling of Cardiogenic Shock: Incorporating Machine Learning Into Bedside Management
Elric Zweck, Song Li, Daniel Burkhoff, et al.
Page
of 7